SG Americas Securities LLC Has $13.68 Million Stake in Medidata Solutions Inc (MDSO)

SG Americas Securities LLC increased its stake in shares of Medidata Solutions Inc (NASDAQ:MDSO) by 882.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 186,773 shares of the company’s stock after acquiring an additional 167,754 shares during the period. SG Americas Securities LLC owned about 0.30% of Medidata Solutions worth $13,679,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of MDSO. Dimensional Fund Advisors LP increased its position in Medidata Solutions by 6.9% during the 3rd quarter. Dimensional Fund Advisors LP now owns 143,913 shares of the company’s stock worth $10,551,000 after purchasing an additional 9,333 shares in the last quarter. LPL Financial LLC increased its position in Medidata Solutions by 25.2% during the 3rd quarter. LPL Financial LLC now owns 15,840 shares of the company’s stock worth $1,161,000 after purchasing an additional 3,185 shares in the last quarter. Man Group plc acquired a new position in Medidata Solutions during the 3rd quarter worth approximately $205,000. Thrivent Financial for Lutherans increased its position in Medidata Solutions by 5.8% during the 3rd quarter. Thrivent Financial for Lutherans now owns 14,280 shares of the company’s stock worth $1,047,000 after purchasing an additional 787 shares in the last quarter. Finally, Macquarie Group Ltd. increased its position in Medidata Solutions by 7.0% during the 3rd quarter. Macquarie Group Ltd. now owns 24,834 shares of the company’s stock worth $1,821,000 after purchasing an additional 1,616 shares in the last quarter.

In other news, EVP Daniel Patrick Shannon sold 19,725 shares of the stock in a transaction on Tuesday, March 12th. The shares were sold at an average price of $75.17, for a total transaction of $1,482,728.25. Following the completion of the sale, the executive vice president now directly owns 70,497 shares in the company, valued at $5,299,259.49. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, EVP Michael Pray sold 15,000 shares of the stock in a transaction on Friday, March 1st. The stock was sold at an average price of $76.50, for a total transaction of $1,147,500.00. Following the sale, the executive vice president now owns 77,134 shares of the company’s stock, valued at $5,900,751. The disclosure for this sale can be found here. Corporate insiders own 4.70% of the company’s stock.

NASDAQ MDSO traded up $0.75 on Wednesday, hitting $91.67. The company’s stock had a trading volume of 477,333 shares, compared to its average volume of 688,920. The company has a debt-to-equity ratio of 0.14, a quick ratio of 2.71 and a current ratio of 2.57. Medidata Solutions Inc has a 1-year low of $60.10 and a 1-year high of $98.60. The stock has a market cap of $5.63 billion, a P/E ratio of 95.49, a price-to-earnings-growth ratio of 8.20 and a beta of 1.42.

Medidata Solutions (NASDAQ:MDSO) last announced its quarterly earnings results on Tuesday, April 30th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.12 by $0.33. Medidata Solutions had a net margin of 7.99% and a return on equity of 9.28%. The firm had revenue of $173.50 million during the quarter, compared to analysts’ expectations of $172.12 million. During the same period in the prior year, the company posted $0.40 EPS. The company’s revenue was up 16.3% on a year-over-year basis. Analysts predict that Medidata Solutions Inc will post 0.79 earnings per share for the current fiscal year.

A number of equities analysts recently issued reports on the stock. Dougherty & Co cut shares of Medidata Solutions from a “buy” rating to a “neutral” rating in a research report on Wednesday, May 1st. Piper Jaffray Companies upped their price objective on shares of Medidata Solutions from $83.00 to $96.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 30th. SunTrust Banks cut shares of Medidata Solutions from a “buy” rating to a “hold” rating and set a $79.00 price objective for the company. in a research report on Wednesday, April 24th. Wells Fargo & Co cut shares of Medidata Solutions from an “outperform” rating to a “market perform” rating and set a $90.00 price target for the company. in a research report on Tuesday, April 23rd. Finally, Guggenheim began coverage on shares of Medidata Solutions in a research report on Wednesday, April 17th. They issued a “buy” rating and a $92.00 price target for the company. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $84.28.

ILLEGAL ACTIVITY NOTICE: “SG Americas Securities LLC Has $13.68 Million Stake in Medidata Solutions Inc (MDSO)” was originally posted by Sundance Herald and is the sole property of of Sundance Herald. If you are accessing this story on another website, it was stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this story can be read at https://sundanceherald.com/2019/05/22/medidata-solutions-inc-mdso-shares-bought-by-sg-americas-securities-llc.html.

Medidata Solutions Company Profile

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management.

Featured Story: Dow Jones Industrial Average (DJIA)

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply